Literature DB >> 24997768

Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose.

Étienne Cavalier1, Valentine Mismetti2, Jean-Claude Souberbielle3.   

Abstract

Irisin is a newly discovered hormone produced by the muscle. This hormone is involved in glucose metabolism, muscle strength and energy expenditure. As vitamin D is also known as a key player in that field, we aimed to see if a single dose of 100,000 IU of vitamin D would modify circulating levels of irisin in 29 young adults. Irisin was determined with the Phoenix Elisa assay at day 0, day 3, day 7 day 15 and day 28 after the loading dose. If we observed a significant increase in 25(OH)D levels (from 19.8±8.4 ng/mL to 33.0±8.5 ng/mL), irisin levels remained constant throughout the study (median 104.5 ng/mL, with values ranging from 69.9 to 390.9 ng/mL). Interestingly, one subject presented irisin values that were three times higher than all the others.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Energy; Irisin; Irisine; Muscle; Vitamin D; Vitamine D; Énergie

Mesh:

Substances:

Year:  2014        PMID: 24997768     DOI: 10.1016/j.ando.2014.05.005

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  5 in total

1.  The Effect of Vitamin D Supplementation on Serum and Muscle Irisin Levels, and FNDC5 Expression in Diabetic Rats.

Authors:  Hoda Nadimi; Abolghassem Djazayery; Mohammad Hassan Javanbakht; Ahmadreza Dehpour; Ehsan Ghaedi; Hoda Derakhshanian; Hamed Mohammadi; Mahnaz Zarei; Mahmoud Djalali
Journal:  Rep Biochem Mol Biol       Date:  2019-10

2.  Upregulation of FNDC5 gene expression in C2C12 cells after single and combined treatments of resveratrol and ATRA.

Authors:  Elahe Abedi-Taleb; Zahra Vahabi; Ehsan Sekhavati-Moghadam; Leila Khedmat; Shima Jazayeri; Ali Akbar Saboor-Yaraghi
Journal:  Lipids Health Dis       Date:  2019-10-22       Impact factor: 3.876

3.  Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.

Authors:  Peivasteh Safarpour; Milad Daneshi-Maskooni; Mohammadreza Vafa; Mitra Nourbakhsh; Leila Janani; Mohsen Maddah; Fatemeh-Sadat Amiri; Fereshteh Mohammadi; Homa Sadeghi
Journal:  BMC Fam Pract       Date:  2020-02-07       Impact factor: 2.497

4.  Irisin Maternal Plasma and Cord Blood Levels in Mothers with Spontaneous Preterm and Term Delivery.

Authors:  Tereza Pavlova; Filip Zlamal; Josef Tomandl; Zuzana Hodicka; Sumeet Gulati; Julie Bienertova-Vasku
Journal:  Dis Markers       Date:  2018-05-28       Impact factor: 3.434

Review 5.  Irisin and Secondary Osteoporosis in Humans.

Authors:  Roberta Zerlotin; Angela Oranger; Patrizia Pignataro; Manuela Dicarlo; Filippo Maselli; Giorgio Mori; Silvia Concetta Colucci; Maria Grano; Graziana Colaianni
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.